Prostamax
Educational information only — not medical advice. Many listed compounds are not FDA-approved for human use. Consult a licensed clinician before starting, changing, or stopping any protocol.
Overview
Prostamax is a short synthetic peptide — the tetrapeptide Lys-Glu-Asp-Pro, often abbreviated KEDP. It belongs to the family of tissue-specific “bioregulator” peptides developed primarily through Russian research, where each peptide is proposed to correspond to a particular organ or tissue. Prostamax is the one associated with the prostate.
It is commonly discussed as a defined-sequence successor to older prostate-derived preparations, and is grouped with other Khavinson peptides such as Vilon, Epithalon, and Cortagen. The concept behind this family is that very short peptides may reach the cell nucleus and influence how genes are read.
Human evidence specific to Prostamax is limited, and much of the published research originates from a single research institute. It is not approved by any major Western regulator for therapeutic use and is sold for research purposes only.
How it works
In laboratory studies, short peptides of this type are reported to interact with chromatin — the packaged form of DNA inside the cell nucleus. Prostamax specifically has been studied for its apparent ability to loosen tightly condensed (“heterochromatin”) regions in the cells of elderly subjects, a process sometimes described as deheterochromatinization, which may reactivate genes that become silenced with age.
Broader reviews of this peptide family propose that such short sequences can penetrate the nucleus and engage DNA and histone proteins to modulate tissue-specific gene expression. These mechanisms are still emerging and have mostly been characterized in preclinical and cell-based settings; the precise mechanism in humans is not established.
Reported benefits
- Support for prostate tissue health (preclinical and small-scale data)
- Modulation of chromatin structure and age-related gene expression in laboratory studies
- Interest as a tissue-specific bioregulator in anti-aging research
These are reported or studied effects, not guaranteed outcomes.
Considerations & side effects
Because rigorous human trials are lacking, the safety profile of synthetic Prostamax is not well characterized, and long-term effects are unknown. While the broader bioregulator category has been described as well tolerated in Russian clinical experience, that record has not been independently verified through Western regulatory review.
Product purity varies widely in the research-chemical market, and material sold under this name may differ in composition. Prostamax is not a substitute for evaluation and treatment of prostate concerns by a qualified clinician.
Frequently asked
What is Prostamax?
Prostamax is a short synthetic peptide (the tetrapeptide Lys-Glu-Asp-Pro, or KEDP) from the Khavinson family of tissue-specific bioregulators, studied for its potential relationship to prostate tissue health.
Is Prostamax FDA-approved?
No. Prostamax is not approved by the FDA or any major Western regulator for human therapeutic use, and is sold for research purposes only.
What does 'bioregulator' mean?
It refers to a class of short peptides, developed largely through Russian research, that are proposed to interact with chromatin and influence tissue-specific gene expression rather than acting like a conventional drug.
How strong is the evidence for Prostamax?
Limited. Most published work comes from a single research group, is preclinical or small in scale, and has not been independently replicated in Western randomized controlled trials.
References
Related compounds
Neuropeptide that stimulates GnRH release, triggering natural testosterone and reproductive hormone production. Used for hormonal assessment and reproductive health support.
Naturally occurring hormone involved in social bonding, mood regulation, and reproductive function. Administered as nasal spray for anxiolytic and social benefits.
Bremelanotide. Melanocortin receptor agonist used for sexual dysfunction. Works on central nervous system.